Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
Johannes vom Berg, Melissa Vrohlings, Sergio Haller, et al.
The Journal of Experimental Medicine (2013) Vol. 210, Iss. 13, pp. 2803-2811
Open Access | Times Cited: 190

Showing 1-25 of 190 citing articles:

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
Michele W.L. Teng, Edward P. Bowman, Joshua McElwee, et al.
Nature Medicine (2015) Vol. 21, Iss. 7, pp. 719-729
Closed Access | Times Cited: 784
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito, Hiroyoshi Nishikawa, Hisashi Wada, et al.
Nature Medicine (2016) Vol. 22, Iss. 6, pp. 679-684
Closed Access | Times Cited: 742
Turning Cold into Hot: Firing up the Tumor Microenvironment
Qianqian Duan, Hualing Zhang, Junnian Zheng, et al.
Trends in cancer (2020) Vol. 6, Iss. 7, pp. 605-618
Open Access | Times Cited: 734
Development and Function of Dendritic Cell Subsets
Alexander Mildner, Steffen Jung
Immunity (2014) Vol. 40, Iss. 5, pp. 642-656
Open Access | Times Cited: 713
Immunotherapy for glioma: Current management and future application
Shengchao Xu, Lu Tang, Xizhe Li, et al.
Cancer Letters (2020) Vol. 476, pp. 1-12
Open Access | Times Cited: 566
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha, Robert L. Martuza, Samuel D. Rabkin
Cancer Cell (2017) Vol. 32, Iss. 2, pp. 253-267.e5
Open Access | Times Cited: 504
Glioma targeted therapy: insight into future of molecular approaches
Keyang Yang, Zhijing Wu, Hao Zhang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 491
New insights into IL-12-mediated tumor suppression
Sònia Tugues, Sara Burkhard, Isabel Ohs, et al.
Cell Death and Differentiation (2014) Vol. 22, Iss. 2, pp. 237-246
Open Access | Times Cited: 479
A Mass Spectrometric-Derived Cell Surface Protein Atlas
Damaris Bausch‐Fluck, Andreas Hofmann, Thomas Bock, et al.
PLoS ONE (2015) Vol. 10, Iss. 4, pp. e0121314-e0121314
Open Access | Times Cited: 410
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
David A. Reardon, Prafulla C. Gokhale, Sarah R. Klein, et al.
Cancer Immunology Research (2015) Vol. 4, Iss. 2, pp. 124-135
Open Access | Times Cited: 388
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Ignacio Melero, Eduardo Castañón, Maite Álvarez, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 9, pp. 558-576
Open Access | Times Cited: 352
Localized Interleukin-12 for Cancer Immunotherapy
Khue G. Nguyen, Maura R. Vrabel, Siena M. Mantooth, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 326
Immunosuppressive mechanisms in glioblastoma: Fig. 1.
Edjah K. Nduom, Michael Weller, Amy B. Heimberger
Neuro-Oncology (2015) Vol. 17, Iss. suppl 7, pp. vii9-vii14
Open Access | Times Cited: 318
Emerging therapies for glioblastoma: current state and future directions
Rong Liang, Ni Li, Zhenzhen Zhang
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 318
Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
William H. Tomaszewski, Luis Sánchez-Pérez, Thomas F. Gajewski, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 14, pp. 4202-4210
Open Access | Times Cited: 272
Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells
Xiaojing Ma, Wenjun Yan, Hua Zheng, et al.
F1000Research (2015) Vol. 4, pp. 1465-1465
Open Access | Times Cited: 242
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
E. Antonio Chiocca, John S. Yu, Rimas V. Lukas, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 505
Open Access | Times Cited: 220
Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
Giulia Agliardi, Anna Rita Liuzzi, Alastair Hotblack, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 214
Interleukin-12: Functional activities and implications for disease
Sebastian Zundler, Markus F. Neurath
Cytokine & Growth Factor Reviews (2015) Vol. 26, Iss. 5, pp. 559-568
Closed Access | Times Cited: 202
IL-12 protects from psoriasiform skin inflammation
Paulina Kulig, Stephanie Musiol, Sandra N. Freiberger, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 179
Engineering interferons and interleukins for cancer immunotherapy
Patrick G. Holder, Shion A. Lim, Christine Huang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114112-114112
Open Access | Times Cited: 96
Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
Atheer Khdyair Hamad, Gaukhar M. Yusubalieva, Владимир П. Баклаушев, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 547-547
Open Access | Times Cited: 61
Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 4
Immunotherapy advances for glioblastoma
D. A. Reardon, Gordon J. Freeman, Catherine J. Wu, et al.
Neuro-Oncology (2014) Vol. 16, Iss. 11, pp. 1441-1458
Open Access | Times Cited: 169
In situ vaccination: Cancer immunotherapy both personalized and off‐the‐shelf
Linda Hammerich, Adam Binder, Joshua Brody
Molecular Oncology (2015) Vol. 9, Iss. 10, pp. 1966-1981
Open Access | Times Cited: 164
Page 1 - Next Page

Scroll to top